World's Best Scientists 2026 revealed!
Odile Launay

Odile Launay

D-Index & Metrics

Immunology

D-Index
68
Citations
18060
World Ranking
2575
National Ranking
107

Overview

Odile Launay is affiliated with Inserm in France and has an extensive publication record primarily in the field of medicine, with a strong focus on infectious diseases and epidemiology. Their research covers a broad range of topics related to vaccines, viral infections, and public health.

Launay's main fields of study include:

  • Medicine

Their subfields of study emphasize:

  • Infectious Diseases
  • Epidemiology
  • Health
  • Public Health, Environmental and Occupational Health
  • General Health Professions

The core research topics addressed by Launay are:

  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 and COVID-19 Research
  • Influenza Virus Research Studies
  • COVID-19 Clinical Research Studies
  • Respiratory viral infections research
  • Viral Infections and Outbreaks Research
  • COVID-19 epidemiological studies

Significant recent publications include:

  • Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial, 2021, The Lancet Infectious Diseases
  • Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review, 2021, Clinical Microbiology and Infection
  • Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial, 2020, The Lancet Infectious Diseases
  • PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study, 2020, The Lancet Infectious Diseases
  • Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement, 2020, Frontiers in Immunology

Launay frequently collaborates with several co-authors, including:

  • Élisabeth Botelho-Nevers
  • Paul Loubet
  • Marie Lachâtre
  • Xavier de Lamballerie
  • Amandine Gagneux-Brunon

Publication venues where Launay has contributed most include:

  • Médecine et Maladies Infectieuses Formation
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Microbiology and Infection
  • Human Vaccines & Immunotherapeutics
  • Vaccine

Best Publications

  • A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation

    Patrick Peretti-Watel;Valérie Seror;Sébastien Cortaredona;Odile Launay

  • Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial

    Jean-Louis Bresson;Christian Perronne;Odile Launay;Catherine Gerdil

  • 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1) pdm09 and B among elderly people in Europe: results from the I-MOVE plus project

    M. Rondy;A. Larrauri;I. Casado;V. Alfonsi

  • Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study.

    Françoise Dromer;Simone Mathoulin-Pélissier;Odile Launay;Olivier Lortholary;Olivier Lortholary

  • Tuberculosis in HIV-infected patients: a comprehensive review

    L. Aaron;D. Saadoun;I. Calatroni;O. Launay

  • Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France

    Pierre Verger;Lisa Fressard;Fanny Collange;Arnaud Gautier

  • The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue.

    Jeremy K Ward;Caroline Alleaume;Patrick Peretti-Watel

  • Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.

    Florence Ader;Maude Bouscambert-Duchamp;Maya Hites;Nathan Peiffer-Smadja;Nathan Peiffer-Smadja

  • Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness

    Ann R. Falsey;Janet E. McElhaney;Jiri Beran;Gerrit A. van Essen

  • Mucosal Imprinting of Vaccine-Induced CD8+ T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors

    Federico Sandoval;Federico Sandoval;Magali Terme;Magali Terme;Mevyn Nizard;Mevyn Nizard;Cécile Badoual;Cécile Badoual

  • Knowledge, attitudes and vaccination coverage of healthcare workers regarding occupational vaccinations.

    P. Loulergue;F. Moulin;G. Vidal-Trecan;Z. Absi

  • Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review

    Simon Galmiche;Liem Binh Luong Nguyen;Eric Tartour;Xavier de Lamballerie

  • Long-term Immune Responses to Vaccination in HIV-Infected Patients: A Systematic Review and Meta-Analysis

    Solen Kernéis;Odile Launay;Clément Turbelin;Clément Turbelin;Frédéric Batteux

  • Safety and Immunogenicity of 4 Intramuscular Double Doses and 4 Intradermal Low Doses vs Standard Hepatitis B Vaccine Regimen in Adults With HIV-1 A Randomized Controlled Trial

    Odile Launay;Diane van der Vliet;Arielle R. Rosenberg;Marie-Louise Michel

  • The French health pass holds lessons for mandatory COVID-19 vaccination

    Unknown

  • AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

    Janet E McElhaney;Jiri Beran;Jeanne-Marie Devaster;Meral Esen

  • Gag Mutations Strongly Contribute to HIV-1 Resistance to Protease Inhibitors in Highly Drug-Experienced Patients besides Compensating for Fitness Loss

    Elisabeth Dam;Romina Quercia;Bärbel Glass;Diane Descamps

  • Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients

    Caroline Charlier;Corneliu Henegar;Odile Launay;Christian Pagnoux

  • Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial.

    A J Pollard;O Launay;Lelievre J-D.;C Lacabaratz

  • Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort.

    Ihsane Hmamouchi;Ihsane Hmamouchi;Kevin Winthrop;Odile Launay;Maxime Dougados

  • A report on the status of vaccination in Europe

    Shazia Sheikh;Eliana Biundo;Soizic Courcier;Oliver Damm

  • Protective effect of A/H1N1 vaccination in immune-mediated disease—a prospectively controlled vaccination study

    Sabine Adler;Anne Krivine;Janine Weix;Flore Rozenberg

Frequent Co-Authors

Fabrice Carrat
Fabrice Carrat Sorbonne University
François Goffinet
François Goffinet Université Paris Cité
Loïc Guillevin
Loïc Guillevin Université Paris Cité
Gilles Pialoux
Gilles Pialoux Tenon Hospital
Bruno Lina
Bruno Lina Claude Bernard University Lyon 1
Luc Mouthon
Luc Mouthon Université Paris Cité
Flore Rozenberg
Flore Rozenberg Université Paris Cité
Jean-Paul Viard
Jean-Paul Viard Assistance Publique – Hôpitaux de Paris
Isabelle Poizot-Martin
Isabelle Poizot-Martin Aix-Marseille University

External Links

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing advanced nursing degrees can open diverse career opportunities in healthcare settings focused on immune-related conditions. Specialized programs such as pmhnp programs online with best clinical placement provide hands-on clinical experience, essential for those aiming to become Psychiatric Mental Health Nurse Practitioners. These programs combine immunology knowledge with mental health care, expanding therapeutic options.

Cost is a crucial consideration for prospective students. Fortunately, there are options such as the cheapest online pmhnp certificate programs that offer quality education without the high price tag. Such programs make advanced education accessible to more learners keen on integrating immunology with psychiatric nursing.

Career advancement often correlates with degree level and specialization. Those with a Doctor of Nursing Practice (DNP) can expect competitive compensation, with variations by region. To see the earning potential, refer to how much do dnp nurses make to better understand salary trends depending on location.

Additionally, nurses looking to shift their focus towards acute immunological care may consider further specialization. Programs like acnp programs facilitate the transition from Family Nurse Practitioner roles to Acute Care Nurse Practitioner positions, aligning with the growing demand for expert care in immunology-related acute conditions.

Best Scientists Citing Odile Launay

Trending Scientists

Recently Published Articles